A Multicentric, Multinational (China and Russia), Randomised, Open, Controlled Study of Immediate 9 Months Adjuvant Hormone Therapy With Triptorelin 11.25 mg Versus Active Surveillance After Radical Prostatectomy in High Risk Prostate Cancer Patients
Phase of Trial: Phase IV
Latest Information Update: 31 Oct 2019
Price : $35 *
At a glance
- Drugs Triptorelin (Primary)
- Indications Adenocarcinoma; Prostate cancer
- Focus Therapeutic Use
- Acronyms PRIORITI
- Sponsors Ipsen
- 25 Oct 2019 Status changed from active, no longer recruiting to completed.
- 24 Jul 2019 Planned End Date changed from 1 Jun 2019 to 1 Sep 2019.
- 24 Jul 2019 Planned primary completion date changed from 1 Jun 2019 to 1 Sep 2019.